We can’t show the full text here under this license.
Abstract
(DKD) is prevalent among patients with diabetes in Korea, necessitating comprehensive treatment strategies.
- Traditional management strategies focus on controlling blood pressure, blood sugar, lipids, and lifestyle factors.
- Four key treatment options may improve DKD outcomes: renin-angiotensin system inhibitors, sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and .
- Future treatment strategies may include precision medicine, digital health, gut health, anti-inflammatory and fibrotic agents, psychosocial support, and regenerative medicine.
- This approach aims to transition from a disease-centered model to a more patient-centered framework.
Simplified